Karla is a drug development company with platform potential aiming to revolutionize the treatment of mental disorders harnessing the immune system.We have discovered a novel protein "Imood" secreted by T cells and increased in the blood of psychiatric patients. We have data supporting the therapeutic interest of Imood-targeting in multiple psychiatric conditions including mood disorders.We are developing anti-Imood therapeutic antibodies to treat psychiatric diseases.Company creation: 2022